Download our white paper to discover how we can help you go from DNA-to-IND in 11 months* 

How can we help you bring your molecule to the clinic?

• From DNA to TOX drug substance in 5 monthsand IND in 11 months*
• Minimum 1.5 kg GMP drug substance for your phase 1 clinical studies*
• Flexible commercial terms
• Improved portability

Our new comprehensive DNA-to-IND program combines speed and quality, while minimizing risk, guaranteeing* delivery of a CMC path to IND for  your monoclonal antibodies in just 11 months.

To gain maximum information on your drug candidate as early as possible, your tox drug substance is delivered in only 5 months allowing you to perform toxicological studies before entering GMP manufacturing.

*For antibodies, from DNA transfection to delivery of CMC enabling IND activities. Subject to terms and conditions.

©2022 Lonza. All Rights Reserved.
Muenchensteinerstrasse 38
Basel 4002
Switzerland